An HLA-A2 polyepitope vaccine for melanoma immunotherapy
L Mateo, J Gardner, Q Chen, C Schmidt… - The Journal of …, 1999 - journals.aai.org
Epitope-based vaccination strategies designed to induce tumor-specific CD8 CTL are being
widely considered for cancer immunotherapy. Here we describe a recombinant poxvirus …
widely considered for cancer immunotherapy. Here we describe a recombinant poxvirus …
[HTML][HTML] Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells
Background Dendritic cells (DCs) are crucial for the efficacy of cancer vaccines, but current
vaccines do not harness the key cDC1 subtype required for effective CD8+ T-cell-mediated …
vaccines do not harness the key cDC1 subtype required for effective CD8+ T-cell-mediated …
[HTML][HTML] Mapping the distinctive populations of lymphatic endothelial cells in different zones of human lymph nodes
SM Park, CE Angel, JD McIntosh, CM Mansell… - PloS one, 2014 - journals.plos.org
The lymphatic sinuses in human lymph nodes (LNs) are crucial to LN function yet their
structure remains poorly defined. Much of our current knowledge of lymphatic sinuses …
structure remains poorly defined. Much of our current knowledge of lymphatic sinuses …
Advance care planning in patients with incurable cancer: study protocol for a randomised controlled trial
Introduction There is limited evidence documenting the effectiveness of Advance Care
Planning (ACP) in cancer care. The present randomised trial is designed to evaluate …
Planning (ACP) in cancer care. The present randomised trial is designed to evaluate …
Clinicopathological characteristics associated with BRAFK601E and BRAFL597 mutations in melanoma
M Voskoboynik, V Mar, S Mailer… - Pigment cell & …, 2016 - Wiley Online Library
BRAF mutations at codons L597 and K601 occur uncommonly in melanoma. Clinical and
pathological associations of these mutations were investigated in a cohort of 1119 patients …
pathological associations of these mutations were investigated in a cohort of 1119 patients …
Viability and quantification of progenitor cells in venesected blood from patients receiving escalated-dose epirubicin and cyclophosphamide with G-CSF for lymphoma …
E O'flaherty, J Cebon, AP Grigg - Leukemia & lymphoma, 1997 - Taylor & Francis
We assessed the concentration of haemopoietic progenitors in peripheral blood in six
patients with de novo intermediate grade non-Hodgkin's lymphoma receiving multiple cycles …
patients with de novo intermediate grade non-Hodgkin's lymphoma receiving multiple cycles …
[CITATION][C] Platelet growth factors: potential impact on transfusion medicine
DJ Kuter, J Cebon, LA Harker, LD Petz… - Transfusion, 1999 - Wiley Online Library
F platelets or to abnormal platelet function. The specific indications for platelet transfusion in
various situations have evolved over the years (Table l). I-'The production and use of …
various situations have evolved over the years (Table l). I-'The production and use of …
[PDF][PDF] Received Date: 21-Oct-2015 Revised Date: 23-Nov-2015 Accepted Date: 27-Nov-2015 Article type
M Voskoboynik, V Mar, S Mailer, A Colebatch… - minerva-access.unimelb.edu.au
BRAF mutations at codons L597 and K601 occur uncommonly in melanoma. Clinical and
pathological associations of these mutations were investigated in a cohort of 1,119 patients …
pathological associations of these mutations were investigated in a cohort of 1,119 patients …
[CITATION][C] MECHANISM OF IGF INDUCED EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) IN MELANOMA PROGRESSION
P Prithviraj, A Jayachandran… - ASIA-PACIFIC …, 2012 - … ST, HOBOKEN 07030-5774, NJ USA